AU2003212142A8 - Downregulation of ca 125 tumor antigen and uses thereof - Google Patents

Downregulation of ca 125 tumor antigen and uses thereof

Info

Publication number
AU2003212142A8
AU2003212142A8 AU2003212142A AU2003212142A AU2003212142A8 AU 2003212142 A8 AU2003212142 A8 AU 2003212142A8 AU 2003212142 A AU2003212142 A AU 2003212142A AU 2003212142 A AU2003212142 A AU 2003212142A AU 2003212142 A8 AU2003212142 A8 AU 2003212142A8
Authority
AU
Australia
Prior art keywords
downregulation
tumor antigen
antigen
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003212142A
Other languages
Unknown language ( )
Other versions
AU2003212142A1 (en
Inventor
Alain Piche
Julie Beaudin
Claudine Rancourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Sherbrooke
Original Assignee
Universite de Sherbrooke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Sherbrooke filed Critical Universite de Sherbrooke
Publication of AU2003212142A8 publication Critical patent/AU2003212142A8/en
Publication of AU2003212142A1 publication Critical patent/AU2003212142A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003212142A 2002-03-11 2003-03-11 Downregulation of ca 125 tumor antigen and uses thereof Abandoned AU2003212142A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36330602P 2002-03-11 2002-03-11
US60/363,306 2002-03-11
CA002420494A CA2420494A1 (en) 2003-02-28 2003-02-28 Ca 125 tumor antigen function and therapeutic uses thereof
CA2,420,494 2003-02-28
PCT/CA2003/000341 WO2003076465A2 (en) 2002-03-11 2003-03-11 Downregulation of ca 125 tumor antigen and uses thereof

Publications (2)

Publication Number Publication Date
AU2003212142A8 true AU2003212142A8 (en) 2003-09-22
AU2003212142A1 AU2003212142A1 (en) 2003-09-22

Family

ID=32873383

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003212142A Abandoned AU2003212142A1 (en) 2002-03-11 2003-03-11 Downregulation of ca 125 tumor antigen and uses thereof

Country Status (3)

Country Link
AU (1) AU2003212142A1 (en)
CA (1) CA2420494A1 (en)
WO (1) WO2003076465A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20050300A (en) 2002-10-16 2007-08-03 Euro-Celtique S.A., Antibodies that bind cell-associated ca 125/0772p and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU717611B2 (en) * 1994-10-28 2000-03-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Tumor-specific antibody fragments, fusion proteins, and uses thereof

Also Published As

Publication number Publication date
WO2003076465A3 (en) 2003-11-13
CA2420494A1 (en) 2004-08-28
WO2003076465A2 (en) 2003-09-18
AU2003212142A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
HK1208472A1 (en) Antibodies that bind cell-associated ca 125/o722p and methods of use thereof ca125/o772p
IL210378A0 (en) Tumor associated antigen, peptides thereof, and use of same as ati-tumor vaccines
HK1205748A1 (en) Therapeutic epitopes and uses thereof
AU2003299734A8 (en) Luminescent polymers and methods of use thereof
ZA200305825B (en) Modified antibodies and methods of use
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
HUP0400284A3 (en) Recombinant tumor specific antibody and use thereof
EP1551447A4 (en) Anti-addl antibodies and uses thereof
AU2003267124A8 (en) Bh3 peptides and method of use thereof
PT3718564T (en) Novel anti-il 13 antibodies and uses thereof
AU2002258790A1 (en) Novel microarrays and methods of use thereof
IL150468A0 (en) Improved micro-needles and methods of manufacture and use thereof
AU2002359512A8 (en) Belts and methods of use thereof
EP1476150A4 (en) Carboxyfullerenes and methods of use thereof
AU2524702A (en) The caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
AU2003239610A8 (en) Tiled biochips and the methods of making the same
IL166063A0 (en) Antibodies and uses thereof
AU2003276844A8 (en) Formulations of modified antibodies and methods of making the same
GB0127657D0 (en) Virulence genes and proteins and their use
AU2003228339A8 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
AU2003212142A8 (en) Downregulation of ca 125 tumor antigen and uses thereof
AU2002227272A1 (en) Ovarian tumor antigen and methods of use therefor
AU2003260487A8 (en) Novel pancortin-pablo protein interactions and methods of use thereof
AU2003249364A8 (en) Algal gdp-mannose-3',5'-epimerases and methods of use thereof
AU2003270518A8 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase